The frequencies of EP300-ZNF384 fusion are 1.3% (2/152) in children and 5.7% (7/122) in adolescent/young adult (AYA)/adult of BCR-ABL1-negative pre-B-ALL patients [19]. Here, ZNF384 is linked to acute lymphoblastic leukemia.